4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0000935836-25-000476
10% owner sold 64,052,538 shares at an average $0.11 ($6,890,236)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| EcoR1 Capital, LLC 10% owner | 2025-07-28 | Sale | −33,931,740 | $0.11 | $3,817,321 | 130,492,680 | I: show line 1 in the form |
| EcoR1 Capital, LLC 10% owner | 2025-07-29 | Sale | −2,687,460 | $0.10 | $271,971 | 127,805,220 | I: show line 2 in the form |
| EcoR1 Capital, LLC 10% owner | 2025-07-30 | Sale | −27,433,338 | $0.10 | $2,800,944 | 100,371,882 | I: show line 3 in the form |
| Open-market sales · 64,052,538 sh · avg $0.11 · $6,890,236 | |||||||
Loading xslF345X05/ownership.xml…